These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16225847)

  • 1. Probing luminal negative charge in the type 3 ryanodine receptor.
    Pugh N; Mead-Savery FC; Coadwell WJ; Rossi D; Sorrentino V; Williams AJ
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1072-9. PubMed ID: 16225847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatic mechanisms underlie neomycin block of the cardiac ryanodine receptor channel (RyR2).
    Mead FC; Williams AJ
    Biophys J; 2004 Dec; 87(6):3814-25. PubMed ID: 15361409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in negative charge at the luminal mouth of the pore alter ion handling and gating in the cardiac ryanodine-receptor.
    Mead-Savery FC; Wang R; Tanna-Topan B; Chen SR; Welch W; Williams AJ
    Biophys J; 2009 Feb; 96(4):1374-87. PubMed ID: 19217855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ryanodine-induced structural alterations in the RyR channel suggested by neomycin block.
    Mead F; Williams AJ
    Biophys J; 2002 Apr; 82(4):1964-74. PubMed ID: 11916854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of the ryanodine receptor channel by neomycin is relieved at high holding potentials.
    Mead F; Williams AJ
    Biophys J; 2002 Apr; 82(4):1953-63. PubMed ID: 11916853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ryanodine receptor pore blocker neomycin also inhibits channel activity via a previously undescribed high-affinity Ca(2+) binding site.
    Laver DR; Hamada T; Fessenden JD; Ikemoto N
    J Membr Biol; 2007 Dec; 220(1-3):11-20. PubMed ID: 17879109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-induced activation of expressed RyR3 at low free calcium.
    Manunta M; Rossi D; Simeoni I; Butelli E; Romanin C; Sorrentino V; Schindler H
    FEBS Lett; 2000 Apr; 471(2-3):256-60. PubMed ID: 10767434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two rings of negative charges in the cytosolic vestibule of type-1 ryanodine receptor modulate ion fluxes.
    Xu L; Wang Y; Gillespie D; Meissner G
    Biophys J; 2006 Jan; 90(2):443-53. PubMed ID: 16239337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin regulation and identification of calmodulin binding region of type-3 ryanodine receptor calcium release channel.
    Yamaguchi N; Xu L; Pasek DA; Evans KE; Chen SR; Meissner G
    Biochemistry; 2005 Nov; 44(45):15074-81. PubMed ID: 16274254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid residues Gln4020 and Lys4021 of the ryanodine receptor type 1 are required for activation by 4-chloro-m-cresol.
    Fessenden JD; Feng W; Pessah IN; Allen PD
    J Biol Chem; 2006 Jul; 281(30):21022-21031. PubMed ID: 16737973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the role of negatively charged amino acid residues in ion permeation of skeletal muscle ryanodine receptor.
    Wang Y; Xu L; Pasek DA; Gillespie D; Meissner G
    Biophys J; 2005 Jul; 89(1):256-65. PubMed ID: 15863483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ryanoid modification of the cardiac muscle ryanodine receptor channel results in relocation of the tetraethylammonium binding site.
    Tanna B; Welch W; Ruest L; Sutko JL; Williams AJ
    J Gen Physiol; 2001 May; 117(5):385-94. PubMed ID: 11331348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further characterization of the type 3 ryanodine receptor (RyR3) purified from rabbit diaphragm.
    Murayama T; Oba T; Katayama E; Oyamada H; Oguchi K; Kobayashi M; Otsuka K; Ogawa Y
    J Biol Chem; 1999 Jun; 274(24):17297-308. PubMed ID: 10358090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unambiguous observation of blocked states reveals altered, blocker-induced, cardiac ryanodine receptor gating.
    Mukherjee S; Thomas NL; Williams AJ
    Sci Rep; 2016 Oct; 6():34452. PubMed ID: 27703263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of the cardiac ryanodine receptor pore-forming region.
    Euden J; Mason SA; Williams AJ
    PLoS One; 2013; 8(6):e66542. PubMed ID: 23776685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 and type 3 ryanodine receptors generate different Ca(2+) release event activity in both intact and permeabilized myotubes.
    Ward CW; Protasi F; Castillo D; Wang Y; Chen SR; Pessah IN; Allen PD; Schneider MF
    Biophys J; 2001 Dec; 81(6):3216-30. PubMed ID: 11720987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryanodine receptor type 3 does not contribute to contractions in the mouse myometrium regardless of pregnancy.
    Matsuki K; Takemoto M; Suzuki Y; Yamamura H; Ohya S; Takeshima H; Imaizumi Y
    Pflugers Arch; 2017 Feb; 469(2):313-326. PubMed ID: 27866274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luminal Ca2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants.
    Qin J; Valle G; Nani A; Nori A; Rizzi N; Priori SG; Volpe P; Fill M
    J Gen Physiol; 2008 Apr; 131(4):325-34. PubMed ID: 18347081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac ryanodine receptor: Selectivity for alkaline earth metal cations points to the EF-hand nature of luminal binding sites.
    Gaburjakova J; Gaburjakova M
    Bioelectrochemistry; 2016 Jun; 109():49-56. PubMed ID: 26849106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imperatoxin a enhances Ca(2+) release in developing skeletal muscle containing ryanodine receptor type 3.
    Nabhani T; Zhu X; Simeoni I; Sorrentino V; Valdivia HH; García J
    Biophys J; 2002 Mar; 82(3):1319-28. PubMed ID: 11867448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.